Overview Quote
Stock Activity
| Day Low - High | 97.46 - 99.33 |
| 52wk Low - High | 81.28 - 116.45 |
| Previous Close | 98.54 |
| Avg. Volume | 3,066,183 |
| Industry | LARGE CAP PHARMA |
| Market Cap | 29.33 B |
| Div - Yield | 0.20 - 0.20 |
| Beta | 0.84 |
| PE (Forward) | 20.73 |
| Current Year Est. | 4.75 |
| Quarterly Earnings ESP |
0.00% |
Premium research
Zacks Rank
|
3 |
Zacks Recommendation
|
Neutral |
Zacks Industry Rank
|
176 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Company Description
Allergan, Inc. is a provider of eye care and specialty pharmaceutical products throughout the world with products in the eye care pharmaceutical, ophthalmic surgical device, over-the-counter contact lens care, movement disorder, and dermatological markets. Its worldwide consolidated revenues are principally generated by prescription and non-prescription pharmaceutical products in the areas of ophthalmology and skin care, neurotoxins, intraocular lenses and other ophthalmic surgical products, and contact lens care products.
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Earnings Estimates
| Current Qtr (06/2013) |
Next Qtr (09/2013) |
Current Year (12/2013) |
Next Year (12/2014) |
|
|---|---|---|---|---|
| Average Estimate | 1.20 | 1.21 | 4.75 | 5.48 |
| Number of Estimates | 15 | 15 | 19 | 18 |
| Low Estimate | 1.18 | 1.18 | 4.71 | 5.28 |
| High Estimate | 1.25 | 1.26 | 4.88 | NA |
| Year Ago EPS | 1.07 | 1.06 | 4.14 | 4.75 |
| EPS Growth | 12.09% | 14.53% | 14.80% | 15.30% |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| ALLERGAN INC | AGN | 98.54 | ![]() |
![]() |
| ABBOTT LABS | ABT | 37.72 | ![]() |
![]() |
| ABBVIE INC | ABBV | 46.54 | ![]() |
![]() |
| ASTRAZENECA PLC | AZN | 51.71 | ![]() |
![]() |
| BAYER A G -ADR | BAYRY | 109.36 | ![]() |
![]() |
| BRISTOL-MYERS | BMY | 44.06 | ![]() |
![]() |
| GLAXOSMITHKLINE | GSK | 52.65 | ![]() |
![]() |
| JOHNSON & JOHNS | JNJ | 88.59 | ![]() |
![]() |
| LILLY ELI & CO | LLY | 55.14 | ![]() |
![]() |
| MERCK & CO INC | MRK | 47.33 | ![]() |
![]() |
Sector:Medical>> Industry:LARGE CAP PHARMA
Zacks Commentary
Positive Opinion on Allergan Candidate
May 06, 2013
Allergan Beats on Earnings
May 01, 2013
A Look at LLY's Early Stage Oncology Pipeline
Apr 12, 2013
Roche Reports 1Q Sales
Apr 12, 2013
SNY's Vaxigrip Filing Accepted in EU
Apr 11, 2013
Roche's New Test for Thyroid Cancer
Apr 11, 2013
SNY's Aubagio Gets Argentinean Nod
Apr 10, 2013
The Zacks Analyst Blog Highlights: Safeway, Valeant Pharmaceuticals, Obagi Medical Products, Allergan and Avanir Pharmaceuticals
Apr 10, 2013
Financials
| EPS TTM | 4.26 |
| Sales | 5,806 |
| Net Income | 882 |
| Price/Earnings | 23.13 |
| Price/Book | 5.47 |
| Price/Cash Flow | 19.90 |
| Price/Sales | 4.99 |
News
Research and Markets Adds Report: Allergan Partnering 2005-2013 - Close-Up Media
May 23, 2013
Allergan (AGN) Showing Bearish Technicals But Could Break Through $100.47 Resistance - Freshbrewedmedia
May 22, 2013
Allergan, Mentor and Galderma Lead the Accelerating European Market for Cosmetic Surgery, Facial Aesthetics and Medical Lasers Reports iData Research Inc. - Globenewswire
May 21, 2013
Allergan, Mentor and Galderma Lead the Accelerating European Market for Cosmetic Surgery, Facial Aesthetics and Medical Lasers Reports iData Research Inc. - Prweb
May 21, 2013
Botox - Is the World's Most Popular Cosmetic Procedure Safe? - Prweb
May 21, 2013
Shares of Allergan Under Pressure, Down 1.5% - Financial News Network Online - Market Movers
May 20, 2013
Allergan Earnings Hindsight: Up 0.7% in Last 17 Days (AGN) - Financial News Network Online - Earnings Lookback
May 18, 2013
Allergan Partnering 2005-2013 Provides an Orientation of Bigpharma's Dealmaking and Business Activities - M2
May 17, 2013
Broker Recommendations
| Current ABR | 1.75 |
| ABR (Last Week) | 1.75 |
| # of recs in ABR | 24 |
| Average Target Price | 114.03 |
| Industry Rank by ABR | 176 out of 265 |
| Rank in Industry | 1 out of 15 |

